JP2014522819A5 - - Google Patents

Download PDF

Info

Publication number
JP2014522819A5
JP2014522819A5 JP2014517394A JP2014517394A JP2014522819A5 JP 2014522819 A5 JP2014522819 A5 JP 2014522819A5 JP 2014517394 A JP2014517394 A JP 2014517394A JP 2014517394 A JP2014517394 A JP 2014517394A JP 2014522819 A5 JP2014522819 A5 JP 2014522819A5
Authority
JP
Japan
Prior art keywords
czlc331
drug
drug according
tat
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014517394A
Other languages
English (en)
Japanese (ja)
Other versions
JP5876930B2 (ja
JP2014522819A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2012/000097 external-priority patent/WO2013004069A1/zh
Publication of JP2014522819A publication Critical patent/JP2014522819A/ja
Publication of JP2014522819A5 publication Critical patent/JP2014522819A5/ja
Application granted granted Critical
Publication of JP5876930B2 publication Critical patent/JP5876930B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014517394A 2011-07-05 2012-01-19 炎症性腸疾患の予防および治療のための薬物の調製におけるサルモネラフラゲリン誘導体の使用 Expired - Fee Related JP5876930B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201110186065 2011-07-05
CN201110186065.6 2011-07-05
PCT/CN2012/000097 WO2013004069A1 (zh) 2011-07-05 2012-01-19 沙门氏菌鞭毛蛋白衍生物在制备防治炎症性肠病药物中的应用

Publications (3)

Publication Number Publication Date
JP2014522819A JP2014522819A (ja) 2014-09-08
JP2014522819A5 true JP2014522819A5 (https=) 2015-03-05
JP5876930B2 JP5876930B2 (ja) 2016-03-02

Family

ID=47436474

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014517394A Expired - Fee Related JP5876930B2 (ja) 2011-07-05 2012-01-19 炎症性腸疾患の予防および治療のための薬物の調製におけるサルモネラフラゲリン誘導体の使用

Country Status (8)

Country Link
US (2) US9259453B2 (https=)
EP (1) EP2730287B1 (https=)
JP (1) JP5876930B2 (https=)
KR (1) KR101814558B1 (https=)
CN (1) CN102861317B (https=)
AU (1) AU2012278744B2 (https=)
CA (1) CA2840924A1 (https=)
WO (1) WO2013004069A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11273198B2 (en) 2017-05-04 2022-03-15 Second Genome, Inc. Proteins for the treatment of epithelial barrier function disorders
US10402165B2 (en) 2017-08-30 2019-09-03 Gsi Technology Inc. Concurrent multi-bit adder
CN108159397A (zh) * 2018-02-28 2018-06-15 中南大学湘雅三医院 一种肠罗斯氏菌重组鞭毛蛋白在制备防治炎症性肠病药物中的应用
CN108404113A (zh) * 2018-05-16 2018-08-17 中国人民解放军军事科学院军事医学研究院 用于抗辐射损伤的口服辐抗肽药物组合物
US20220218786A1 (en) * 2019-03-28 2022-07-14 The Catholic University Of Korea Industry-Academic Cooperation Foundation Composition for preventing or treating graft-versus-host disease comprising tlr5 agonist derived from flagellin as effective component
CN110420317B (zh) * 2019-07-25 2022-11-22 中国人民解放军军事科学院军事医学研究院 Cblb502蛋白在防治创伤后应激障碍中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050073865A (ko) * 2004-01-12 2005-07-18 대한민국(전남대학교총장) 비브리오 패혈증균 편모 구성인자 플라젤린을유효성분으로 함유하는 백신 보조제
EP2460534A1 (en) * 2004-12-22 2012-06-06 Cleveland Clinic Foundation Flagellin related polypeptides and uses thereof
EP2374474A1 (en) * 2005-01-19 2011-10-12 Vaxinnate Corporation Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response
CA2531261A1 (en) * 2005-12-21 2007-06-21 Institut Pasteur Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
BRPI0911604A2 (pt) * 2008-04-25 2015-12-15 Inst Systems Biology vacinas de polipeptídeo de flagelina
CN101411872A (zh) 2008-11-25 2009-04-22 中国科学院武汉病毒研究所 预防龋齿的疫苗试剂盒及其使用方法

Similar Documents

Publication Publication Date Title
JP2014522819A5 (https=)
TWI482626B (zh) 胃腸道病症的治療
JP2015517489A5 (https=)
TWI504610B (zh) 阿肽加定衍生物、其製備方法及其用途
JP2017504590A5 (https=)
JP2017519739A5 (https=)
JP2018527392A5 (https=)
TWI797116B (zh) 用於治療上皮細胞屏障功能病症的蛋白質
CN106999544A (zh) 包含pli‑ob蛋白质变体的口服施用的组合物
JP2017221201A5 (https=)
JP2014529399A5 (https=)
JP7590401B2 (ja) 改変されたescherichia coli株nissle及び胃腸障害の処置
JP2012508698A5 (https=)
US20210380994A1 (en) Lactococcus lactis expression system for delivering proteins efficacious for the treatment of epithelial barrier function disorders
US9630999B2 (en) Use of Salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases
CA3250172A1 (en) PEPTIDE INHIBITORS OF THE INTERLEUKIN-23 RECEPTOR AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS
JP6930919B2 (ja) 結腸洗浄及び胃腸障害の治療のための組成物
JP2022513199A5 (https=)
JP2015531749A5 (https=)
Alizadeh et al. Identification of novel peptides against TNF-α using phage display technique and in silico modeling of their modes of binding
Sapula et al. Antimicrobial drug efflux pumps in Staphylococcus aureus
JP2009505991A5 (https=)
JP2016516726A5 (https=)
CN101016332A (zh) 一种抑制志贺毒素的短肽及其用途
JP6841404B2 (ja) ペプチド